log in | register
Username
Password
Remember me
Journals
Services
Search
Advanced search
Summary
April 2005, Vol. 6, No. 4, Pages 583-590
(doi:10.1517/14656566.6.4.583)

Nystagmus: an update on treatment in adults
Andreas Straube
University of Munich, Department of Neurology, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany. astraube@nefo.med.uni-muenchen.de



Recent developments in the treatment of nystagmus in adults have changed the traditional approach to such illnesses as benign paroxysmal positional vertigo, vestibular neuritis, Meniere´s disease, superior canal dehiscence syndrome, vestibular paroxysmia, superior oblique myokymia, downbeat/upbeat nystagmus and acquired pendular nystagmus, as well as periodic alternating nystagmus. Treatments reported to suppress nystagmus, with tolerable side effects, are now available for some of these syndromes. Due to the absence of large controlled studies, however, treatment recommendations rest only on class C evidence.

Forward Links to Citing Articles

Michael Strupp, Thomas Brandt. (2006) Pharmacological advances in the treatment of neuro-otological and eye movement disorders. Current Opinion in Neurology 19:1, 33???40
CrossRef
PDF (139.62 KB) PDF Plus (268.851 KB)
 

Prev. Article | Next Article
View/Print PDF (140 KB)
View PDF Plus (269 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

Quick Links
 • Alert me when:
New articles cite this article
 • Download to citation manager
 • Related articles found in:
Expert Opinion series
 • View Most Downloaded Articles
 
 
Quick Search
for 
Author:
Andreas Straube
Keywords:
acquired pendular nystagmus
benign paroxysmal positional vertigo
downbeat and upbeat nystagmus
Meniere´s disease
periodic alternating nystagmus
superior canal dehiscence syndrome
superior oblique myokymia
treatment of nystagmus
vestibular neuritis
vestibular paroxysmia


Informa Healthcare, Telephone House, 69-77 Paul Street, London, EC2A 4LQ, UK
Tel: +44 (0)20 7017 5000 · Fax: +44 (0)20 7017 7667
We welcome your Feedback. See our Privacy Statement and Terms and Conditions